167 related articles for article (PubMed ID: 34645615)
1. Plasma protein
Memarian E; 't Hart LM; Slieker RC; Lemmers RFL; van der Heijden AA; Rutters F; Nijpels G; Schoep E; Lieverse AG; Sijbrands EJG; Wuhrer M; van Hoek M; Dotz V
BMJ Open Diabetes Res Care; 2021 Oct; 9(1):. PubMed ID: 34645615
[TBL] [Abstract][Full Text] [Related]
2. IgG N-glycans are associated with prevalent and incident complications of type 2 diabetes.
Memarian E; Heijmans R; Slieker RC; Sierra A; Gornik O; Beulens JWJ; Hanic M; Elders P; Pascual J; Sijbrands E; Lauc G; Dotz V; Barrios C; 't Hart LM; Wuhrer M; van Hoek M
Diabetes Metab Res Rev; 2023 Oct; 39(7):e3685. PubMed ID: 37422864
[TBL] [Abstract][Full Text] [Related]
3. Metformin and statin use associate with plasma protein
Singh SS; Naber A; Dotz V; Schoep E; Memarian E; Slieker RC; Elders PJM; Vreeker G; Nicolardi S; Wuhrer M; Sijbrands EJG; Lieverse AG; 't Hart LM; van Hoek M
BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32616483
[TBL] [Abstract][Full Text] [Related]
4. Plasma protein N-glycan signatures of type 2 diabetes.
Dotz V; Lemmers RFH; Reiding KR; Hipgrave Ederveen AL; Lieverse AG; Mulder MT; Sijbrands EJG; Wuhrer M; van Hoek M
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2613-2622. PubMed ID: 30251656
[TBL] [Abstract][Full Text] [Related]
5. Associations between plasma protein, IgG and IgA N-glycosylation and metabolic health markers in pregnancy and gestational diabetes.
Štambuk T; Kifer D; Smirčić-Duvnjak L; Vučić Lovrenčić M; Gornik O
PLoS One; 2023; 18(4):e0284838. PubMed ID: 37079606
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes.
Naber A; Demus D; Slieker RC; Nicolardi S; Beulens JWJ; Elders PJM; Lieverse AG; Sijbrands EJG; 't Hart LM; Wuhrer M; van Hoek M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791405
[TBL] [Abstract][Full Text] [Related]
7. Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.
Clerc F; Novokmet M; Dotz V; Reiding KR; de Haan N; Kammeijer GSM; Dalebout H; Bladergroen MR; Vukovic F; Rapp E; ; Targan SR; Barron G; Manetti N; Latiano A; McGovern DPB; Annese V; Lauc G; Wuhrer M
Gastroenterology; 2018 Sep; 155(3):829-843. PubMed ID: 29792883
[TBL] [Abstract][Full Text] [Related]
8. Serum protein N-glycosylation changes in multiple myeloma.
Zhang Z; Westhrin M; Bondt A; Wuhrer M; Standal T; Holst S
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):960-970. PubMed ID: 30844485
[TBL] [Abstract][Full Text] [Related]
9. MALDI-TOF-MS reveals differential N-linked plasma- and IgG-glycosylation profiles between mothers and their newborns.
Jansen BC; Bondt A; Reiding KR; Scherjon SA; Vidarsson G; Wuhrer M
Sci Rep; 2016 Sep; 6():34001. PubMed ID: 27666402
[TBL] [Abstract][Full Text] [Related]
10. Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic Health.
Reiding KR; Ruhaak LR; Uh HW; El Bouhaddani S; van den Akker EB; Plomp R; McDonnell LA; Houwing-Duistermaat JJ; Slagboom PE; Beekman M; Wuhrer M
Mol Cell Proteomics; 2017 Feb; 16(2):228-242. PubMed ID: 27932526
[TBL] [Abstract][Full Text] [Related]
11. Plasma
Wittenbecher C; Štambuk T; Kuxhaus O; Rudman N; Vučković F; Štambuk J; Schiborn C; Rahelić D; Dietrich S; Gornik O; Perola M; Boeing H; Schulze MB; Lauc G
Diabetes Care; 2020 Mar; 43(3):661-668. PubMed ID: 31915204
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes.
Keser T; Gornik I; Vučković F; Selak N; Pavić T; Lukić E; Gudelj I; Gašparović H; Biočina B; Tilin T; Wennerström A; Männistö S; Salomaa V; Havulinna A; Wang W; Wilson JF; Chaturvedi N; Perola M; Campbell H; Lauc G; Gornik O
Diabetologia; 2017 Dec; 60(12):2352-2360. PubMed ID: 28905229
[TBL] [Abstract][Full Text] [Related]
13. Association of IgG N-glycomics with prevalent and incident type 2 diabetes mellitus from the paradigm of predictive, preventive, and personalized medicine standpoint.
Meng X; Wang F; Gao X; Wang B; Xu X; Wang Y; Wang W; Zeng Q
EPMA J; 2023 Mar; 14(1):1-20. PubMed ID: 36866157
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the human and bovine milk N-glycome via high-performance microfluidic chip liquid chromatography and tandem mass spectrometry.
Nwosu CC; Aldredge DL; Lee H; Lerno LA; Zivkovic AM; German JB; Lebrilla CB
J Proteome Res; 2012 May; 11(5):2912-24. PubMed ID: 22439776
[TBL] [Abstract][Full Text] [Related]
15. Diet affects glycosylation of serum proteins in women at risk for cardiometabolic disease.
Kim T; Xie Y; Li Q; Artegoitia VM; Lebrilla CB; Keim NL; Adams SH; Krishnan S
Eur J Nutr; 2021 Oct; 60(7):3727-3741. PubMed ID: 33770218
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus.
Singh SS; Rashid M; Lieverse AG; Kronenberg F; Lamina C; Mulder MT; de Rijke YB; Sijbrands EJG; van Hoek M
Diabetologia; 2020 Jun; 63(6):1248-1257. PubMed ID: 32152647
[TBL] [Abstract][Full Text] [Related]
17. IgG glycan patterns are associated with type 2 diabetes in independent European populations.
Lemmers RFH; Vilaj M; Urda D; Agakov F; Šimurina M; Klaric L; Rudan I; Campbell H; Hayward C; Wilson JF; Lieverse AG; Gornik O; Sijbrands EJG; Lauc G; van Hoek M
Biochim Biophys Acta Gen Subj; 2017 Sep; 1861(9):2240-2249. PubMed ID: 28668296
[TBL] [Abstract][Full Text] [Related]
18. N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters.
Testa R; Vanhooren V; Bonfigli AR; Boemi M; Olivieri F; Ceriello A; Genovese S; Spazzafumo L; Borelli V; Bacalini MG; Salvioli S; Garagnani P; Dewaele S; Libert C; Franceschi C
PLoS One; 2015; 10(3):e0119983. PubMed ID: 25793407
[TBL] [Abstract][Full Text] [Related]
19. Association of the IgG
Singh SS; Heijmans R; Meulen CKE; Lieverse AG; Gornik O; Sijbrands EJG; Lauc G; van Hoek M
BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32349995
[TBL] [Abstract][Full Text] [Related]
20. Human complement component C3 N-glycome changes in type 1 diabetes complications.
Šoić D; Štambuk J; Tijardović M; Keser T; Lauc G; Bulum T; Lovrenčić MV; Rebrina SV; Tomić M; Novokmet M; Smirčić-Duvnjak L; Gornik O
Front Endocrinol (Lausanne); 2023; 14():1101154. PubMed ID: 37293493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
